{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T21:20:09Z","timestamp":1776547209927,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","advancesradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.adro.2025.101756","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:32:02Z","timestamp":1741221122000},"page":"101756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tolerance of Adjuvant Ultrahypofractionated Whole-Breast Radiation Therapy Employing Moderately Hypofractionated Sequential Boost: A Single Institution Analysis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8746-3814","authenticated-orcid":false,"given":"Olga","family":"Unterkirhere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tino","family":"Streller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Logaritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dubsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Glanzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Studer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2025.101756_bib0001","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2025.101756_bib0002","series-title":"Radiotherapy Dose Fractionation","year":"2023"},{"key":"10.1016\/j.adro.2025.101756_bib0003","unstructured":"National Clinical Guideline. Treatment of patients with breast cancer: Radiation oncology, NCCP Breast Cancer Guideline Development Group (radiation oncology subgroup), Ireland. 2023. Accessed January 31, 2024.https:\/\/www.hse.ie\/eng\/services\/list\/5\/cancer\/profinfo\/guidelines\/breast\/treatment-of-patients-with-breast-cancer-radiation-oncology.pdf"},{"key":"10.1016\/j.adro.2025.101756_bib0004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clon.2022.03.001","article-title":"From 25 fractions to five: How hypofractionation has revolutionised adjuvant breast radiotherapy","volume":"34","author":"Yarnold","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2025.101756_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00066-020-01744-3","article-title":"Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward","volume":"197","author":"Krug","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2025.101756_bib0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0008","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clon.2020.03.006","article-title":"International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic","volume":"32","author":"Coles","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2025.101756_bib0009","article-title":"Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands","volume":"47","author":"Eijkelboom","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.prro.2023.10.009","article-title":"Early and intermediate treatment outcome after postoperative external beam accelerated partial breast irradiation in patients with early-stage breast cancer","volume":"14","author":"Stenger-Weisser","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0011","article-title":"Single institution prospective evaluation of moderately Hypofractionated Whole Breast Radiotherapy with simultaneous integrated boost with or without lymphatic drainage irradiation after breast conserving surgery","volume":"8","author":"Unterkirhere","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0012","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"32","author":"Moran","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0013","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"34","author":"Morrow","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0014","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1245\/s10434-019-08160-7","article-title":"Validation of a novel nomogram for prediction of local relapse after surgery for invasive breast carcinoma","volume":"27","author":"Corso","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2015.12.027","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1","volume":"118","author":"Offersen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0016","unstructured":"FAST-Forward. Randomised clinical trial testing a 1-week course of curative whole breast radiotherapy against a standard 3-week schedule in terms of local cancer control and late adverse effects in patients with early breast cancer. Version 5.1 05\/02\/2018. Accessed August 20, 2024.https:\/\/www.icr.ac.uk\/media\/docs\/default-source\/default-document-library\/fast-forward-protocol.pdf?sfvrsn=421a2169_0"},{"key":"10.1016\/j.adro.2025.101756_bib0017","unstructured":"Planning Pack for the FAST-Forward Trial. Version 3. 2013. Accessed February 18, 2025.https:\/\/www.eviq.org.au\/getmedia\/a9d88369-191a-4b91-8fa8-9bcbf431d675\/3650-OAR-notes-FAST-Forward-pdf.aspx"},{"key":"10.1016\/j.adro.2025.101756_bib0018","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Accessed June 20, 2023. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"},{"key":"10.1016\/j.adro.2025.101756_bib0019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-8140(95)90055-1","article-title":"LENT SOMA tables","volume":"35","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0360-3016(79)90729-6","article-title":"Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast","volume":"5","author":"Harris","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101756_bib0021","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41598-019-57094-3","article-title":"The prognostic and predictive potential of Ki-67 in triple-negative breast cancer","volume":"10","author":"Zhu","year":"2020","journal-title":"Sci Rep"},{"issue":"5 Suppl","key":"10.1016\/j.adro.2025.101756_bib0022","first-page":"GS5","article-title":"Hypofractionated Radiotherapy in patients with Breast Cancer (HRBC): Acute toxicity data of a phase III randomized study","volume":"83","author":"Yadav","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2025.101756_bib0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13063-023-07851-7","article-title":"HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): A non-inferiority, open-label, phase III randomized trial","volume":"25","author":"Yadav","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.adro.2025.101756_bib0024","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101756_bib0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ijrobp.2023.10.018","article-title":"Physician- and patient-reported outcomes of the MC1635 phase 3 trial of ultrahypofractionated versus moderately hypofractionated adjuvant radiation therapy after breast-conserving surgery","volume":"118","author":"Laughlin","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101756_bib0026","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T09:14:16Z","timestamp":1747214056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109425000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2452109425000442"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2025.101756","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerance of Adjuvant Ultrahypofractionated Whole-Breast Radiation Therapy Employing Moderately Hypofractionated Sequential Boost: A Single Institution Analysis","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2025.101756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101756"}}